; the molecular basis for this sex bias remains unclear. An important regulatory mechanism of colonic homeostasis is via noncanonical estrogen receptor (ER) signaling. Very low levels of circulating estrogen are required to bind transmembrane and cytosolic ERs, such that immune responses in both sexes are subject to regulation by estrogen. Estrogen receptor b (ERb) is expressed abundantly in the human colon, 4, 5 where it has a critical role in maintaining barrier function and colonic architecture. 6, 7 We therefore examined the in vivo functional effects of ERb gainof-function and loss-of-function using a dextran sulfate sodium-induced murine model of acute experimental colitis (DSS-AEC).
We challenged ERb-deficient mice (ERb-knockout [KO]), ERa-deficient mice (ERa-KO), or wild-type littermate controls (WT) with DSS-AEC and measured clinical parameters including weight loss ( Figure 1A ), disease activity index ( Figure 1B and Supplementary  Figure 1 ), colon length ( Figure 1C ), and total inflammatory scores including percentage ulceration, reepithelialization, active and chronic inflammation, and transmural inflammation ( Figure 1D and Supplementary Figure 2) . We also performed experimental endoscopies 8 to assess inflammation and tissue damage ( Figure 1E ) and histologic assessment of DSStreated colon tissues ( Figure 1F ). Interestingly, ERa-KO-male (M) mice lost the most weight of any group, whereas ERa-KO-female (F) mice lost very little weight ( Figure 1A ). ERa-KO-M also showed the most severe disease activity index scores ( Figure 1B ) and the most significant colon shortening ( Figure 1C) , with significant interaction effects between genotype and sex. Based on H&E staining of colon tissues, total inflammatory scores showed similarly exacerbated colitis among ERa-KO-M mice ( Figure 1D ). Experimental endoscopies showed that ERa-KO-F mice appeared nearly normal, whereas ERa-KO-M mice showed focal ulcerative lesions with spontaneous bleeding and loss of colon transparency ( Figure 1E ). Histologic assessment showed profound inflammation, epithelial erosion, and loss of tissue architecture in ERa-KO-M mice as well as ERb-KO-F mice ( Figure 1F) .
ERb has been shown to be a dominant-negative regulator of ERamediated signaling, 9 leading us to postulate that sex-specific differences in colonic gene expression of ERa or ERb may underlie sex-based differences in response to DSS-AEC. Interestingly, we found that knockdown of each individual ER isoform results in compensatory up-regulation of the other (Supplementary Figure 3) , a pattern that occurs to a similar extent in both sexes and is therefore unlikely to contribute to sex-based differences.
We next analyzed the potential differences in colonic gene expression between DSS-treated ERa-KO-M and ERa-KO-F mice using a polymerase chain reaction array of 84 known ER-regulated genes. All gene expression values were normalized to the B2m gene, and z-scores were calculated for all genes (full data set) (Supplementary Figure 4A) . Trimming the data for genes that are significantly and uniquely different between ERa-KO-M and ERa-KO-F DSS-treated colon tissues (Supplementary Materials and Methods section and Supplementary Figure 4B ) resulted in the identification of cathepsin D (Ctsd), Fos, and Socs3.
Gene expression of Socs3, Ctsd, and Fos was confirmed by traditional quantitative polymerase chain reaction in a larger colon tissue sample set from DSS-treated ERa-KO-M and ERa-KO-F mice. In agreement with the array data, all 3 genes showed higher expression among DSS-treated ERa-KO-M compared with ERa-KO-F mice ( Figure 2A ). Interestingly, Ctsd and Fos both showed sex-specific differences in gene expression after DSS-AEC: Ctsd expression was reduced significantly in ERa-KO-F mice, but unchanged in ERa-KO-M mice, whereas Fos expression was increased significantly in ERa-KO-M mice, but unchanged in ERa-KO-F mice ( Figure 2A ). Gene expression of SOCS3, CTSD, and FOS in UC patients or control colon biopsy specimens showed that CTSD expression was reduced in female UC patients compared with controls, whereas male UC patients and controls expressed similar CTSD levels ( Figure 2B ). In contrast, male UC patients expressed higher FOS compared with controls, whereas female UC patients and controls expressed similar FOS levels ( Figure 2B ). No significant difference between male and female control or UC patients in gene expression of ERa or ERb ( Figure 2C and D) was observed, suggesting that the differences observed in Fos and Ctsd are not owing to differential ERa/ERb expression.
Our findings suggest that fundamental differences in ERa/ERb signaling ratios impact colitis in males and females. Specifically, ERb expression in female mice protected against DSS colitis, whereas it failed to protect male mice. Our findings provide insight toward potential mechanisms by which sex-based differences in intestinal inflammation arise. We propose that signaling downstream of ERa/ERb results in differential gene expression in males vs females, ultimately leading to enhanced colitis in males. Improved understanding of the mechanisms by which loss of ERa signaling fails to protect males from colonic inflammation may eventually lead to more specific and efficacious UC therapies.
See editorial on page 638. Figure 1 . DSS-induced colitis in WT, ERb-KO, and ERa-KO male and female mice. Ten-to 12-week-old male (M) and female (F) WT, ERb-KO, and ERa-KO mice were fed 2.5% DSS-supplemented drinking water for 5 days and killed on day 6. (A) Body weights were recorded at days 0, 5, and 6 and are expressed as the percentage of initial (day 0) weight. (B) The disease activity index (DAI) was calculated for each mouse at day 6 (encompassing body weight loss, stool consistency, and hemoccult scores). Analysis of variance (ANOVA) F ¼ 36.3; P < .0001; a ¼ .05 with 2 df. (C) Colon length was measured on day 6 (ANOVA F ¼ 12.4; P < .0001, a ¼ .05 with 2 df). (D) H&E-stained colon tissues collected from mice on day 6 were assessed for total inflammatory scores (TIS, encompassing ulceration; re-epithelization; active and chronic inflammation; and transmural inflammation; ANOVA F ¼ 57.06 for interaction effects; P < .0001; a ¼ .05 with 2 df). Data are represented as the means ± SEM of 7-17 individual mice/group; dots represent individual values. *P .05, **P .01, and ***P .001. (E) Endoscopic evaluations were performed of the descending colon on day 6, immediately before death. Arrows represent loss of transparency (red), bleeding (blue), and focal edematous lesions (green). (F) Distal colon tissues were harvested for H&E staining. Scale bar: 10 mm; original magnification, 10Â þ 1.25 numerical aperture (NA). Author contributions Wendy A. Goodman was responsible for the study concept and design, acquisition of data, analysis/interpretation of data, drafting of the manuscript, statistical analysis, and obtaining funding; Hannah L. Havran, Humzah A. Quereshy, Steven Kuang, and Carlo De Salvo acquired data; and Theresa T. Pizarro was responsible for the study concept and design, critical revision of the manuscript, obtaining funding, and study supervision.
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Supplementary Materials and Methods

Human Tissue Samples
All studies involving human subjects were approved by the Institutional Review Board of University Hospitals Cleveland Medical Center (Cleveland, OH). Colon biopsy samples were obtained from the Biorepository Core of the Cleveland Digestive Diseases Research Core Center. UC samples were obtained from areas of active inflammation, from adult patients before the initiation of biologic therapies, or after a wash-out period of 3 weeks or more after biologic therapies. Control biopsy specimens were obtained from routine colonoscopy screenings of non-inflammatory bowel disease patients. The mean ages were 57 ± 6 years (UC) and 49 ± 7 years (control). All samples were collected after obtaining informed consent. 
Induction of DSS Colitis
Experimental colitis was induced in 8-to 12-week-old ERa-KO, ERb-KO, and WT littermate mice with 2.5% wt/vol DSS (molecular weight, 36,000-50,000 daltons; MP Biomedicals, Solon, OH) dissolved in sterile drinking water given ad libitum for 5 days, followed by 1 day of tap water. 3 Mice were killed on day 6.
Murine Endoscopy
Endoscopies were performed on DSS-treated mice on day 6, immediately before death, as previously described. 4 Briefly, an Olympus (Olympus, Center Valley, PA) URF-V flexible endoscope was inserted into the rectum of anesthetized, immobilized mice and slowly advanced through the descending colon until reaching the left colic flexure (proximal/ transverse colon). Videos were recorded throughout, using narrow-band imaging. An integrated endoscopic scoring system 4 was used to objectively assess 4 parameters of colorectal inflammation: perianal findings, intestinal transparency, intestinal bleeding, and the presence of focal lesions.
Histologic Assessment of Colonic Inflammation
The full length of colon from experimental mice was removed, flushed of fecal contents, opened longitudinally, and fixed for 24 hours in Bouin's solution. Seventy percent of ethanolrinsed tissues then were embedded in paraffin, cut to 3 mm, and stained with H&E. Disease severity was evaluated by a board-certified pathologist in a blinded fashion using an established histologic scoring system for colitis. Briefly, 5 individual components were assessed for each tissue sample: degree of ulceration, re-epithelialization, active inflammation, chronic inflammation, and transmural inflammation. Each component was scored on a scale of 0-12 for the degree of severity and the percentage of colon tissue showing involvement. The 5 subscores were added to calculate the total inflammatory score. Images were obtained on an Axiophot microscope, captured on an Axiocam, and assembled using Axiovision Release 4.5 (Carl Zeiss, Thornwood, NY).
RNA Isolation and Gene Expression Analysis
Total RNA was isolated from homogenized colon tissue samples using TRIzol (phenol-chloroform) extraction (ThermoFisher, Waltham, MA). Before tissue homogenization, colon tissue was washed thoroughly with phosphatebuffered saline to ensure no carry-over of DSS, which has been shown to inhibit the enzymatic activity of polymerase and reverse transcriptase. 5 Reverse transcription was performed using the Transcriptor First Strand Complementary DNA Synthesis Kit (Roche, Indianapolis, IN) according to the manufacturer's instructions. Quantitative real-time polymerase chain reaction was performed using TaqMan primer/probe sets specific for indicated genes (ThermoFisher) on an ABI StepOne Plus thermocycler (ThermoFisher). Expression of target genes was normalized to that of a housekeeping gene (Gapdh or B2m), and fold changes were calculated using the delta-delta CT (ddCT) method. 6 All samples were assayed in triplicate.
Quantitative Polymerase Chain Reaction Array
Total RNA was isolated from homogenized colon tissue samples using TRIzol (phenol-chloroform) extraction (ThermoFisher). Reverse-transcription was performed using the RT 2 First Strand Kit (SABiosciences, Germantown, MD) according to the manufacturer's instructions. Complementary DNA from 3 individual mice was pooled for each sample used for the PCR array. Samples were analyzed using the mouse estrogen signaling RT2 Profiler PCR Array (SABiosciences) and run on an ABI Step One Plus quantitative polymerase chain reaction machine (ThermoFisher). Data were analyzed using online freeware (RT 2 Profiler PCR Array Data Analysis, version 3.5; SABiosciences).
Statistical Analysis and Data Interpretation
A 2-tailed Student t test with Welch correction and Bonferroni test were performed using GraphPad Prism 7 (GraphPad Software, La Jolla, CA). P values .05 were considered significant. Where indicated, 2-way analysis of variance was performed to assess interaction effects between groups. All authors had full access to the study data and reviewed and approved the final manuscript.
